Biosimilars and Interchangeable Biologics: Strategic Elements - Image 1

£230.60

CRC Press Biosimilars and Interchangeable Biologics: Strategic Elements

Name: Biosimilars and Interchangeable Biologics: Strategic Elements
Brand: CRC Press
Price: 230.6 GBP
Availability: InStock

Biomedical Engineering

This is the most expensive it has ever been. Walk away.

£231 today · previous high £231 · all-time low £67

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 613 days • 613 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 613 days • 4 price ranges

Days at Price

Current Price

Price Analysis

Most common range: £165-198 (321 days, 52.4%)

Price range: £67 - £231

Price levels: 4 price ranges over 613 days

Description

What’s the Deal with Biosimilars? Biosimilars are gaining momentum as new protein therapeutic candidates that can help fill a vital need in the healthcare industry. The biological drugs are produced by recombinant DNA technology that allows for large-scale production and an overall reduction time in costs and development. Part of a two-volume set that covers varying aspects of biosimilars, Biosimilars and Interchangeable Biologics: Strategic Elements explores the strategic planning side of biosimilar drugs and targets issues surrounding biosimilars that are linked to legal matters. This includes principal patents and intellectual property, regulatory pathways, and concerns about affordability on a global scale. It addresses the complexity of biosimilar products, and it discusses the utilization of biosimilars and related biological drugs in expanding world markets. Of specific interest to practitioners, researchers, and scientists in the biopharmaceutical industry, this volume examines the science, technology, finance, legality, ethics, and politics of biosimilar drugs. It considers strategic planning elements that include an overall understanding of the history and the current status of the art and science of biosimilars, and it provides detailed descriptions of the legal, regulatory, and commercial characteristics. The book also presents a global strategy on how to build, take to market, and manage the next generation of biosimilars throughout their life cycle.

Product Specifications

Brand: CRC Press
Format: Hardcover
ASIN: 1498743471
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions > Biomedical Engineering
Domain: Amazon UK
Release Date: 27 January 2016
Listed Since: 04 May 2015

Barcode

No barcode data available

CRC Press Biosimilars and Interchangeable Biologics: Strategic Elements

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Biosimilars and Interchangeable Biologics: Tactical Elements

Biosimilars and Interchangeable Biologics: Tactical Elements

Biosimilars Development Strategies: Fast to Market Approaches

Biosimilars: A New Generation of Biologics

Biosimilars: A New Generation of Biologics

Biologics and Biosimilars: Drug Discovery and Clinical Applications

Biosimilar and Interchangeable Biologics: From Cell Line to Commercial Launch, Two Volume Set

Commercialization of BioPharma Products in the USA (BW): A Practical Guide

Nonclinical Development of Novel Biologics, Biosimilars and Specialty Biologics

Biosimilars and Interchangeable Biologics: Strategic Elements

ASHP Biosimilars and Biologics - Implementation and Monitoring

Biosimilar Drug Product Development (Drugs and the Pharmaceutical Sciences)

Mastering Strategic Marketing For Specialty Pharmaceuticals: A Hands-on Guide

Biosimilar Clinical Development: Scientific Considerations and New Methodologies (Chapman & Hall/CRC Biostatistics Series)

Regulatory Protection in the Pharmaceutical and Life Science Industries: Challenges, Opportunities and Ongoing Reform (Elgar Monographs in Intellectual Property Law)

Digital Therapeutics: Strategic, Scientific, Developmental, and Regulatory Aspects (Chapman & Hall/CRC Biostatistics Series)

Biopharmaceutical Supply Chains: Distribution, Regulatory, Systems and Structural Changes Ahead

Benefit-Risk Assessment in Pharmaceutical Research and Development (Chapman & Hall/CRC Biostatistics Series)

Real-World Evidence in a Patient-Centric Digital Era (Chapman & Hall/CRC Biostatistics Series)

Medical Product Regulatory Affairs: Pharmaceuticals, Diagnostics, Medical Devices

Artificial Intelligence for Drug Product Lifecycle Applications

The 2023-2028 Outlook for Bioengineered Monoclonal Antibodies Protein Drugs in Japan

Dorosz guide pratique des medicaments 2023, 42e ed

Medical Writing in Drug Development: A Practical Guide for Pharmaceutical Research